Darazalex IV infusion 400mg, manufactured by Janssen Pharmaceutical, contains Daratumumab (genetical recombination), a CD38-directed cytolytic antibody. It is used to treat multiple myeloma, often in combination with other therapies. This 400mg 20mL 1 bottle has a YJ code of 4291437A2024.
Darazalex IV infusion 400mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).